The pharmaceutical sector is looking to technology, especially Big Data, to power innovation and growth, as pricing power comes under more pressure.
Some companies with a lot of pricing power and lot of growth through price, and not innovation, are having to start to rethink their pipelines and investments because of the scrutiny on pricing.
Get more in-depth coverage of how technology could affect drug development and innovation. Ask your Morgan Stanley representative or Financial Advisor for the full BluePaper report, “Digitizing Drug Development: How Much Can It Save?" (Apr 6, 2017). Plus, more Ideas.